Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193)-II. Relationship between dose level and biochemical effects in P388 leukemia in vivo

Hiremagalur N. Jayaram, Antoinette L. Smith, Robert I. Glazer, David G. Johns, David A. Cooney

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Administration of the novel thiazole C-nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193), to BDF1 mice bearing subcutaneous implants of P388 leukemia provoked a sharp depression in the concentration of intratumoral guanine nucleotides and a correspondingly large expansion of the IMP pools. Measurements of IMP dehydrogenase in the tumors of treated mice revealed that this enzyme was inhibited in a dose-responsive way, with ∼50% inhibition engendered by the administration of the drug at a dose of 25 mg/kg and > 90% inhibition by all doses > 100 mg/kg. The inhibition of enzyme activity, seen after a dose of 250 mg/kg, reached a maximum 120 min after treatment and had subsided substantially 8 hr after dosing; by 24 hr, enzyme activity was fully restored. These results, coupled with the observation that the antitumor activity of the drug could be prevented in large part by the simultaneous administration of guanosine, support the conclusion that 2-β-d-ribofuranosylthiazole-4-carboxamide, after anabolism, exerts its antineoplastic effects via a state of guanine nucleotide depletion. In extracts of the tumors of mice given parenteral injections of the thiazole nucleoside, a potent dialyzable inhibitor of IMP dehydrogenase was demonstrable; its concentration fluctuated in parallel with enzyme inhibition. Although the chemical identity of the proximate inhibitory species has yet to be established, it is concluded on kinetic grounds that it is neither the native nucleoside nor its 5′-monophosphate.

Original languageEnglish (US)
Pages (from-to)3839-3845
Number of pages7
JournalBiochemical Pharmacology
Volume31
Issue number23
DOIs
StatePublished - Dec 1 1982
Externally publishedYes

Fingerprint

tiazofurin
Leukemia P388
IMP Dehydrogenase
Nucleosides
Enzyme inhibition
Thiazoles
Guanine Nucleotides
Enzyme activity
Tumors
Bearings (structural)
Enzymes
Antineoplastic Agents
Inosine Monophosphate
Guanosine
Pharmaceutical Preparations
Neoplasms
Kinetics
Injections

ASJC Scopus subject areas

  • Pharmacology

Cite this

Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193)-II. Relationship between dose level and biochemical effects in P388 leukemia in vivo. / Jayaram, Hiremagalur N.; Smith, Antoinette L.; Glazer, Robert I.; Johns, David G.; Cooney, David A.

In: Biochemical Pharmacology, Vol. 31, No. 23, 01.12.1982, p. 3839-3845.

Research output: Contribution to journalArticle

Jayaram, Hiremagalur N. ; Smith, Antoinette L. ; Glazer, Robert I. ; Johns, David G. ; Cooney, David A. / Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193)-II. Relationship between dose level and biochemical effects in P388 leukemia in vivo. In: Biochemical Pharmacology. 1982 ; Vol. 31, No. 23. pp. 3839-3845.
@article{265be9663cf442e49e9f67d23a2bd5ef,
title = "Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193)-II. Relationship between dose level and biochemical effects in P388 leukemia in vivo",
abstract = "Administration of the novel thiazole C-nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193), to BDF1 mice bearing subcutaneous implants of P388 leukemia provoked a sharp depression in the concentration of intratumoral guanine nucleotides and a correspondingly large expansion of the IMP pools. Measurements of IMP dehydrogenase in the tumors of treated mice revealed that this enzyme was inhibited in a dose-responsive way, with ∼50{\%} inhibition engendered by the administration of the drug at a dose of 25 mg/kg and > 90{\%} inhibition by all doses > 100 mg/kg. The inhibition of enzyme activity, seen after a dose of 250 mg/kg, reached a maximum 120 min after treatment and had subsided substantially 8 hr after dosing; by 24 hr, enzyme activity was fully restored. These results, coupled with the observation that the antitumor activity of the drug could be prevented in large part by the simultaneous administration of guanosine, support the conclusion that 2-β-d-ribofuranosylthiazole-4-carboxamide, after anabolism, exerts its antineoplastic effects via a state of guanine nucleotide depletion. In extracts of the tumors of mice given parenteral injections of the thiazole nucleoside, a potent dialyzable inhibitor of IMP dehydrogenase was demonstrable; its concentration fluctuated in parallel with enzyme inhibition. Although the chemical identity of the proximate inhibitory species has yet to be established, it is concluded on kinetic grounds that it is neither the native nucleoside nor its 5′-monophosphate.",
author = "Jayaram, {Hiremagalur N.} and Smith, {Antoinette L.} and Glazer, {Robert I.} and Johns, {David G.} and Cooney, {David A.}",
year = "1982",
month = "12",
day = "1",
doi = "10.1016/0006-2952(82)90300-8",
language = "English (US)",
volume = "31",
pages = "3839--3845",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "23",

}

TY - JOUR

T1 - Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193)-II. Relationship between dose level and biochemical effects in P388 leukemia in vivo

AU - Jayaram, Hiremagalur N.

AU - Smith, Antoinette L.

AU - Glazer, Robert I.

AU - Johns, David G.

AU - Cooney, David A.

PY - 1982/12/1

Y1 - 1982/12/1

N2 - Administration of the novel thiazole C-nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193), to BDF1 mice bearing subcutaneous implants of P388 leukemia provoked a sharp depression in the concentration of intratumoral guanine nucleotides and a correspondingly large expansion of the IMP pools. Measurements of IMP dehydrogenase in the tumors of treated mice revealed that this enzyme was inhibited in a dose-responsive way, with ∼50% inhibition engendered by the administration of the drug at a dose of 25 mg/kg and > 90% inhibition by all doses > 100 mg/kg. The inhibition of enzyme activity, seen after a dose of 250 mg/kg, reached a maximum 120 min after treatment and had subsided substantially 8 hr after dosing; by 24 hr, enzyme activity was fully restored. These results, coupled with the observation that the antitumor activity of the drug could be prevented in large part by the simultaneous administration of guanosine, support the conclusion that 2-β-d-ribofuranosylthiazole-4-carboxamide, after anabolism, exerts its antineoplastic effects via a state of guanine nucleotide depletion. In extracts of the tumors of mice given parenteral injections of the thiazole nucleoside, a potent dialyzable inhibitor of IMP dehydrogenase was demonstrable; its concentration fluctuated in parallel with enzyme inhibition. Although the chemical identity of the proximate inhibitory species has yet to be established, it is concluded on kinetic grounds that it is neither the native nucleoside nor its 5′-monophosphate.

AB - Administration of the novel thiazole C-nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193), to BDF1 mice bearing subcutaneous implants of P388 leukemia provoked a sharp depression in the concentration of intratumoral guanine nucleotides and a correspondingly large expansion of the IMP pools. Measurements of IMP dehydrogenase in the tumors of treated mice revealed that this enzyme was inhibited in a dose-responsive way, with ∼50% inhibition engendered by the administration of the drug at a dose of 25 mg/kg and > 90% inhibition by all doses > 100 mg/kg. The inhibition of enzyme activity, seen after a dose of 250 mg/kg, reached a maximum 120 min after treatment and had subsided substantially 8 hr after dosing; by 24 hr, enzyme activity was fully restored. These results, coupled with the observation that the antitumor activity of the drug could be prevented in large part by the simultaneous administration of guanosine, support the conclusion that 2-β-d-ribofuranosylthiazole-4-carboxamide, after anabolism, exerts its antineoplastic effects via a state of guanine nucleotide depletion. In extracts of the tumors of mice given parenteral injections of the thiazole nucleoside, a potent dialyzable inhibitor of IMP dehydrogenase was demonstrable; its concentration fluctuated in parallel with enzyme inhibition. Although the chemical identity of the proximate inhibitory species has yet to be established, it is concluded on kinetic grounds that it is neither the native nucleoside nor its 5′-monophosphate.

UR - http://www.scopus.com/inward/record.url?scp=0020450359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020450359&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(82)90300-8

DO - 10.1016/0006-2952(82)90300-8

M3 - Article

C2 - 6130768

AN - SCOPUS:0020450359

VL - 31

SP - 3839

EP - 3845

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 23

ER -